Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide

Yun Gyu Park, Serkin Park, Seoung Ok Lim, Moon Seop Lee, Chong Kun Ryu, Insun Kim, Yoon S. Cho-Chung

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)


We have previously demonstrated that the activation of p53 signaling may contribute to tumor growth inhibition by the CRE-decoy oligonucleotide containing CRE sequence (5′-TGACGTCA-3′) (Lee et al., Biochemistry 39, 4863-4868, 2000). However, growth inhibition by CRE-decoy treatment was also observed in tumor cells containing a mutant p53 (Park et al., J. Biol. Chem. 274, 1573-1580, 1999). To understand additional mechanisms of the decoy oligonucleotide, we investigated the effect on cyclin D1 expression and a cyclin D1/Cdk4/retinoblastoma protein (pRB) signaling pathway. Here we show that in MCF7 breast cancer cells the CRE-decoy competed with cyclin D1-CRE (5′-TAACGTCA-3′) for binding transcription factors and reduced cyclin D1 gene expression (in reporter gene assay, Northern blotting and Western blotting) to modulate cyclin D1/Cdk4/pRB signaling and G1-S progression in a steady state and/or under estrogen stimulation. Decrease of cyclin D1 protein level by CRE-decoy treatment was also observed in p53-mutated cancer cells. Cyclin D1 expression was also diminished in MCF7 cells stably expressing dominant negative mutant CREB indicating that the nonspecific effect of oligonucleotide or its degradation products could be excluded. These data suggest that inhibition of cyclin D1 expression contributes to the growth inhibition induced by the decoy oligonucleotide in MCF7 cells through a cyclin D1/Cdk4/pRB signaling pathway. Downregulation of cyclin D1 expression also provides a mechanism of CRE-decoy-induced growth inhibition in tumor cells having p53 mutation.

Original languageEnglish
Pages (from-to)1213-1219
Number of pages7
JournalBiochemical and biophysical research communications
Issue number5
Publication statusPublished - 2001

Bibliographical note

Funding Information:
1This work was supported in part by grants from the Korea Research Foundation (2000-041-F00014) and Medical Science Research Center at Korea University (1999-203). 2To whom correspondence and reprint requests should be addressed at 126-1, 5-ga, Anam-dong, Sungbuk-gu, Seoul, 136-701, Korea. Fax: 82-2-923-0480. E-mail:


  • CRE-decoy oligonucleotide
  • Cyclin D1
  • G1 phase arrest
  • Retinoblastoma protein
  • Tumor growth inhibition

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide'. Together they form a unique fingerprint.

Cite this